CPSC
IHE icon

Carl P. Sherr & Co’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Carl P. Sherr & Co’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,681
Closed -$220K – 112
2020
Q4 		$220K Hold
3,681
– – 0.18% 103
2020
Q3 		$201K Buy
+3,681
New +$199K 0.18% 103

Other funds holding IHE

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Carl P. Sherr & Co's IHE Position: Q1 2021 in Review

Carl P. Sherr & Co sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2021, closing a stake of 3,681 shares — an estimated $220K sold.

Carl P. Sherr & Co first reported a position in IHE in Q3 2020 and held it in 2 quarters. The position peaked at $220K in Q4 2020. 101 funds tracked by Wall St. Rank hold IHE as of Q1 2021.

  • Carl P. Sherr & Co reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2021 after selling out during the quarter.
  • Carl P. Sherr & Co sold 3,681 iShares US Pharmaceuticals ETF shares in Q1 2021, an estimated $220K.
  • Carl P. Sherr & Co first reported a position in iShares US Pharmaceuticals ETF in Q3 2020 and held it in 2 quarters.
  • Carl P. Sherr & Co's iShares US Pharmaceuticals ETF position peaked at $220K in Q4 2020.
  • 101 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2021.

Based on Carl P. Sherr & Co's 13F filing for Q1 2021, filed 13 Apr 2021.